Implanet received approval under the CE Mark to market the JAZZ® Passer, part of the company's JAZZ spinal fusion platform.
The device, designed in response to voice of surgeon customer, facilitates placement of the JAZZ band around anatomical structures in posterior fixation procedures. It includes spinal instruments and braided band technology compatible with all JAZZ platform implant connectors.
Passer received FDA 510(k) clearance at the end of 3Q17.
Sources: Implanet; ORTHOWORLD Inc.